Vanguard Health Care (VGHAX) has a new manager, Rebecca Sykes. Well, maybe not so new. Sykes, who started with the fund as an analyst in 2007, joined Jean Hynes as comanager in 2023.
But at the start of 2025, Hynes stepped away from the fund — though she’ll stay on as chief executive of Wellington Management, the fund’s subadviser, a position she’s held since early 2021. “The change is part of a thoughtful, long-term succession plan,” a Vanguard spokesman said.
Health Care, which has $40.5 billion in assets, is the big kahuna of its category, so Sykes’s new role as sole manager — the third in the fund’s 40-year history — is noteworthy.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Challenges lie ahead. Although Health Care had the best 30-year annualized record of any U.S. stock mutual fund at the end of 2016, it has had uneven returns of late, and its 10-year annualized return now ranks below average.
Health Care Fund strategy
We’ll be watching the fund closely. Every new manager makes their mark on a fund, even if they’re well schooled in the previous manager’s ways. That said, Sykes says she will carry on the firm’s research-driven, team-focused and collaborative approach. And like Hynes, she will focus on undervalued companies of all sizes all over the world (non-U.S. stocks make up 27% of the fund’s portfolio) that are poised to play key roles in the future of medicine and healthcare.
“I believe innovation will continue to drive value over the long term,” says Sykes.
The fund typically balances hefty stakes in the managers’ highest-conviction stocks with smaller holdings in baskets of stocks to gain exposure to specific subsectors or themes. Top holding Eli Lilly (LLY), for instance, represents almost 10% of the fund’s assets.
But in 2024, with biotech shares languishing, the fund initiated new stakes in five biotech firms, including Avidity Biosciences and Crinetics Pharmaceuticals.
Help for healthcare stocks
Sykes says she’s excited about the future of healthcare. Clarity on the new administration’s policy on drug pricing, vaccines and government insurance programs could “help lift healthcare stocks,” she says. And new data for medicine to treat obesity, high cholesterol and lung cancer could “advance the standards of care and help reinvigorate the performance of biotech stocks.”
Note: This item first appeared in Kiplinger Personal Finance Magazine, a monthly, trustworthy source of advice and guidance. Subscribe to help you make more money and keep more of the money you make here.
Related content
-
Retirement Savings On Track? How Much Should You Have Between 61 and 65JPMorgan’s guide can help baby boomers determine whether they have saved enough for a retirement pegged to their income level.
-
Family Caregivers Need Help. These Are the Policies They Say Would Make the Biggest DifferenceThere are millions of people across the country caring for elderly or disabled family members. New research shows the key changes that would improve their lives and the lives of those they care for.
-
What You Don't Know About Annuities Can Hurt YouLack of awareness leads many to overlook these potent financial tools, and with the possibility of running out of money in retirement, that could really hurt.
-
Three Keys to Logical Investing When Markets Are VolatileFocusing on these market fundamentals can help investors stay grounded rather than being swayed by emotion or market hysteria.
-
Yes, the Markets Are Spooked, But You Don't Have to BeIt's human nature for investors to freak out in a downturn. But with a little discipline, you can overcome the urge to sell and stay focused on long-term goals.
-
Remembering Bogle: A New Standard for Municipal InvestingImprovements in technology, data, systematic trading and risk analytics have led to more successful municipal indexing.
-
Stock Market Today: Stocks Are Mixed Before Liberation DayMarkets are getting into the freewheeling rhythm of a second Trump administration.
-
How to Invest in SportsIf it's springtime, Forbes is out with its annual list of baseball franchise values. The billions involved might make you wonder how to invest in sports.
-
Winning Strategies for Financial Advisers as Clients' Lives EvolveHow can the wealth management industry help make life transitions easier for the adviser and the client?
-
How Advisers Can Establish Relationships With HNW ProspectsThese strategies can help to build influence with high-net-worth individuals, who are often looking to an adviser for insight rather than solutions.
